|Institution||University of Ljubljana, Faculty of Medicine (UL MF)|
Prof .Dolžan is a Full Professor of Biochemistry and Molecular Biology at the Faculty of Medicine, University of Ljubljana, where she lectures Biochemistry, Molecular Biology and Pharmacogenetics at the undergraduate and graduate level. She is the founder and Head of the Pharmacogenetics Laboratory at the Institute of Biochemistry, Faculty of Medicine.
She is the PI of the national research programme Molecular mechanisms of regulation of cellular processes related to some human diseases (P1-0170). She has vast research experience in the field of pharmacogenetics and implementation of novel molecular biology based methods into clinical use. She published over 70 SCI indexed papers that have over 2000 citations. She investigates the influence of genetic variability in drug metabolizing enzymes, transporters and drug targets on drug treatment response in drug treatment. Cancer treatment is of major interest, however she is also very active in pharmacogenetic research in anticoagulant, antidiabetic, antipsychotic, antidepressant, antirheumatic and, antiepileptic drug treatment. She is particularly interested in development of clinical-pharmacogenetic models that would facilitate the translation of personalized medicine into clinical practice.
She brought together Slovenian pathologists, gastroenterologists and surgeons dealing with pancreatic cancer to promote genomic and pharmacogenomic research of pancreatic cancer as Slovenian Pancreatic Cancer Working Group. She also works on the promotion of pharmacogenomics knowledge and awareness among Slovenian medical professionals and general public. In 2013 she received Lapanje award from the Slovenian Biochemical Society as a professional recognition of outstanding contribution to the development of biochemical science in Slovenian and international arena and for the successful transfer of scientific research findings into clinical practice.